ixekizumab
Showing 1 - 25 of 33
Plaque Psoriasis Trial in Outram Park (Ixekizumab, Methotrexate, Cyclosporin A)
Recruiting
- Plaque Psoriasis
- Ixekizumab
- +3 more
-
Outram Park, SingaporeSingapore General Hospital
Nov 23, 2022
Plaque Psoriasis, Psoriatic Arthritis Trial in India (Ixekizumab)
Not yet recruiting
- Plaque Psoriasis
- Psoriatic Arthritis
- Ixekizumab
-
Raipur, Chhattisgarh, India
- +14 more
May 4, 2023
Type1 Diabetes Trial in Sweden (Ixekizumab, Placebo)
Recruiting
- Type1 Diabetes Mellitus
- Ixekizumab
- Placebo
-
Borås, Sweden
- +17 more
Dec 5, 2022
Spondyloarthritis Trial in China (Ixekizumab, Placebo)
Completed
- Spondyloarthritis
- Ixekizumab
- Placebo
-
Bengbu, Anhui, China
- +18 more
Jun 20, 2022
Molecular Signatures in Inflammatory Skin Disease
Recruiting
- Atopic Dermatitis
- Psoriasis
- Ustekinumab
- +9 more
-
Kiel, GermanyDepartment of Dermatology, University Hospital Schleswig Holstei
Jul 16, 2022
Generalized Pustular Psoriasis, Erythrodermic Psoriasis Trial in Japan (Ixekizumab)
Completed
- Generalized Pustular Psoriasis
- Erythrodermic Psoriasis
- Ixekizumab
-
Nagoya, Aichi, Japan
- +6 more
Jul 21, 2021
MDD Trial in New York (Ixekizumab, Placebo)
Recruiting
- Major Depressive Disorder
- Ixekizumab
- Placebo
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Nov 16, 2021
Psoriatic Arthritis, Withdrawal, Reduction Trial in Erlangen (Prednisolone, Sulfasalazine, Leflunomide)
Recruiting
- Psoriatic Arthritis
- +2 more
- Prednisolone
- +14 more
-
Erlangen, Bavaria, GermanyUniversitätsklinikum Erlangen
Nov 10, 2022
Covid19 Trial in Ribeirão Preto, Santo André (Ixekizumab, Aldesleukin, Colchicine)
Completed
- Covid19
- Ixekizumab
- +3 more
-
Ribeirão Preto, SP, Brazil
- +1 more
Jul 26, 2022
Rheumatoid Arthritis, Psoriatic Arthritis, Spondylarthritis Trial in Birmingham, Omaha (Upadacitinib, Abatacept, Secukinumab)
Recruiting
- Rheumatoid Arthritis
- +2 more
- Upadacitinib
- +7 more
-
Birmingham, Alabama
- +7 more
Sep 19, 2022
Plaque Psoriasis Trial in China (Ixekizumab, Placebo)
Completed
- Plaque Psoriasis
- Ixekizumab
- Placebo
-
Beijing, Beijing, China
- +16 more
Jun 3, 2021
Pityriasis Rubra Pilaris Trial in Portland (Ixekizumab)
Completed
- Pityriasis Rubra Pilaris
- Ixekizumab
-
Portland, OregonOregon Health and Science University
Jun 15, 2020
Bullous Pemphigoid, Pemphigoid Trial in Scottsdale (Ixekizumab)
Completed
- Bullous Pemphigoid
- Pemphigoid
- Ixekizumab
-
Scottsdale, ArizonaMayo Clinic
May 11, 2020
Axial Spondyloarthritis Trial in Worldwide (Ixekizumab, Placebo)
Completed
- Axial Spondyloarthritis
- Ixekizumab
- Placebo
-
Phoenix, Arizona
- +126 more
May 12, 2022
Psoriasis Trial in New York (Ixekizumab)
Completed
- Psoriasis
- Ixekizumab
-
New York, New YorkMount Sinai School of Medicine Dermatology Clinical Trials
Sep 6, 2019
Psoriatic Arthritis Trial in Worldwide (Ixekizumab, Adalimumab)
Completed
- Psoriatic Arthritis
- Ixekizumab
- Adalimumab
-
Ciudad Autonoma de Buenos Aire, Buenos Aires, Argentina
- +130 more
Oct 9, 2020
Plaque Psoriasis Trial in Canada, Puerto Rico, United States (Ixekizumab, Guselkumab, Placebo)
Completed
- Plaque Psoriasis
- Ixekizumab
- +2 more
-
Birmingham, Alabama
- +123 more
Jul 10, 2020
Plaque Psoriasis Trial in Worldwide (Ixekizumab, Placebo)
Completed
- Plaque Psoriasis
- Ixekizumab
- Placebo
-
Birmingham, Alabama
- +124 more
Jun 10, 2020